On May 17, 2021, Oxford University and Oracle announced they had created a Global Pathogen Analysis System combining Oxfordﾒs Scalable Pathogen Pipeline Platform (SP3) with the power of Oracle Cloud Infrastructure (OCI).

Coupled with the extensive machine learning capabilities in the Oracle Cloud, collaborating scientists, researchers, and governments worldwide can process, analyse, visualise, and act on a wide collection of COVID-19 pathogen data for the first time. This includes identifying variants of interest and their potential impact on vaccine and treatment effectiveness. To-date, Oxford had processed half the world’s SARS-CoV-2 sequences, more than 500,000 in total.